SciBase Changes Certified Adviser to Carnegie Investment Bank AB (Publ)
SciBase Changes Certified Adviser to Carnegie Investment Bank AB (Publ)
Vator SecuritiesSTOCKHOLM, Aug. 21, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), SciBase, a leading developer of augmented intelligence-based solutions for skin, hereby announces change of Certified Adviser from Vator Securities to Carnegie Investment Bank AB (publ).
STOCKHOLm, 2024年8月21日 / PRNewswire -- SciBase Holding Ab（"SciBase"）（STO：SCIB），SciBase是皮膚醫學領域領先的基於增強智能技術的解決方案開發商，特此宣佈將認證顧問從瓦特證券更換爲卡內基投資銀行股份有限公司（publ）。
SciBase has entered into an agreement with Carnegie Investment Bank AB (publ) regarding the position as Certified Adviser. Carnegie Investment Bank AB (publ) will assume the role of Certified Adviser effective from September 1, 2024. Until then, Vator Securities will continue to act as the Certified Adviser for the company.
SciBase已與卡內基投資銀行股份有限公司（publ）達成協議，就擔任認證顧問一職達成協議。卡內基投資銀行股份有限公司（publ）將自2024年9月1日起擔任認證顧問。在此之前，瓦特證券將繼續擔任該公司的認證顧問。
For additional information, please contact:
Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected]
Certified Advisor (CA):
欲了解更多信息，請聯繫:
Pia Renaudin，VD，電話+46 732069802，電子郵件：[email protected]
認證顧問（CA）：
Vator Securities
Tel: +46 8 580 065 99
Email: [email protected]
Vator Securities
電話：+46858006599
電子郵件：[email protected]
About SciBase:
關於SciBase：
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
SciBase是一家全球性醫療技術公司，專注於皮膚疾病的早期檢測和預防。SciBase開發和商業化Nevisense，這是一種獨特的點對點平台，結合了人工智能和先進的電阻抗譜技術，提高了診斷準確性，確保積極的皮膚健康管理。
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
我們致力於減少患者的痛苦，使臨床醫生通過及時檢測和干預來改善和挽救生命，並降低醫療保健成本。
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
SciBase在瑞典斯德哥爾摩的卡羅林斯卡學院進行了20多年的研究，是皮膚病學進展的領先者。
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at . All press releases and financial reports can be found here:
該公司自2015年6月2日起已在納斯達克第一北部增長市場交易所上市。在此處了解更多。所有新聞發佈和財務報告均可在此處找到：
This information was brought to you by Cision
本信息由Cision提供
The following files are available for download:
以下文件可供下載：
|
PM_byte CA eng |
|
PM_byte CA eng |
譯文內容由第三人軟體翻譯。